nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—psoriasis—skin cancer	0.858	1	CtDrD
Fluocinolone Acetonide—Keratosis pilaris—Vemurafenib—skin cancer	0.0204	0.151	CcSEcCtD
Fluocinolone Acetonide—Pustule—Imiquimod—skin cancer	0.00616	0.0457	CcSEcCtD
Fluocinolone Acetonide—Abrasion NOS—Imiquimod—skin cancer	0.00508	0.0376	CcSEcCtD
Fluocinolone Acetonide—Papule—Imiquimod—skin cancer	0.00382	0.0283	CcSEcCtD
Fluocinolone Acetonide—Skin infection—Imiquimod—skin cancer	0.00276	0.0205	CcSEcCtD
Fluocinolone Acetonide—Excoriation—Imiquimod—skin cancer	0.00276	0.0205	CcSEcCtD
Fluocinolone Acetonide—Condition aggravated—Temozolomide—skin cancer	0.00274	0.0203	CcSEcCtD
Fluocinolone Acetonide—Eye infection—Imiquimod—skin cancer	0.00269	0.0199	CcSEcCtD
Fluocinolone Acetonide—Rash papular—Vemurafenib—skin cancer	0.00262	0.0195	CcSEcCtD
Fluocinolone Acetonide—Fluocinonide—SMO—skin cancer	0.00216	0.837	CrCbGaD
Fluocinolone Acetonide—Leukoderma—Imiquimod—skin cancer	0.00196	0.0145	CcSEcCtD
Fluocinolone Acetonide—Telangiectasia—Fluorouracil—skin cancer	0.00195	0.0145	CcSEcCtD
Fluocinolone Acetonide—Skin striae—Bleomycin—skin cancer	0.00186	0.0138	CcSEcCtD
Fluocinolone Acetonide—Common cold—Fluorouracil—skin cancer	0.00176	0.0131	CcSEcCtD
Fluocinolone Acetonide—Eyelid oedema—Imiquimod—skin cancer	0.00165	0.0122	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Vemurafenib—skin cancer	0.00156	0.0115	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Imiquimod—skin cancer	0.0014	0.0104	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Imiquimod—skin cancer	0.00133	0.00983	CcSEcCtD
Fluocinolone Acetonide—Allergic contact dermatitis—Fluorouracil—skin cancer	0.00132	0.00977	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Vismodegib—skin cancer	0.00115	0.00851	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Imiquimod—skin cancer	0.00107	0.00794	CcSEcCtD
Fluocinolone Acetonide—Skin irritation—Fluorouracil—skin cancer	0.00106	0.00789	CcSEcCtD
Fluocinolone Acetonide—Rash pustular—Imiquimod—skin cancer	0.00105	0.00775	CcSEcCtD
Fluocinolone Acetonide—Photopsia—Docetaxel—skin cancer	0.00104	0.00774	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Bleomycin—skin cancer	0.000996	0.00738	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Imiquimod—skin cancer	0.000923	0.00684	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Imiquimod—skin cancer	0.000905	0.00671	CcSEcCtD
Fluocinolone Acetonide—Folliculitis—Dactinomycin—skin cancer	0.000879	0.00651	CcSEcCtD
Fluocinolone Acetonide—Visual acuity reduced—Temozolomide—skin cancer	0.00084	0.00623	CcSEcCtD
Fluocinolone Acetonide—Lacrimation—Fluorouracil—skin cancer	0.000783	0.0058	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Vismodegib—skin cancer	0.000781	0.00579	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Fluorouracil—skin cancer	0.000774	0.00574	CcSEcCtD
Fluocinolone Acetonide—Blepharitis—Fluorouracil—skin cancer	0.000748	0.00555	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Vemurafenib—skin cancer	0.00071	0.00526	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Vismodegib—skin cancer	0.000702	0.0052	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Vismodegib—skin cancer	0.000692	0.00513	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Vismodegib—skin cancer	0.000677	0.00502	CcSEcCtD
Fluocinolone Acetonide—Eczema—Imiquimod—skin cancer	0.000673	0.00499	CcSEcCtD
Fluocinolone Acetonide—Back pain—Vismodegib—skin cancer	0.000669	0.00496	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Temozolomide—skin cancer	0.000642	0.00476	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—nipple—skin cancer	0.000633	0.133	CbGeAlD
Fluocinolone Acetonide—Pain in extremity—Imiquimod—skin cancer	0.000605	0.00449	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Vismodegib—skin cancer	0.000589	0.00437	CcSEcCtD
Fluocinolone Acetonide—Wheezing—Bleomycin—skin cancer	0.000575	0.00426	CcSEcCtD
Fluocinolone Acetonide—Lacrimation—Docetaxel—skin cancer	0.000565	0.00419	CcSEcCtD
Fluocinolone Acetonide—Skin hyperpigmentation—Docetaxel—skin cancer	0.000559	0.00414	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Vismodegib—skin cancer	0.000554	0.0041	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Temozolomide—skin cancer	0.000553	0.0041	CcSEcCtD
Fluocinolone Acetonide—Infestation—Vemurafenib—skin cancer	0.000547	0.00405	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Vemurafenib—skin cancer	0.000547	0.00405	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Temozolomide—skin cancer	0.000542	0.00402	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Fluorouracil—skin cancer	0.000539	0.004	CcSEcCtD
Fluocinolone Acetonide—Influenza—Imiquimod—skin cancer	0.000523	0.00388	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000514	0.00381	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Fluorouracil—skin cancer	0.0005	0.0037	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Fluorouracil—skin cancer	0.0005	0.0037	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Vismodegib—skin cancer	0.000487	0.00361	CcSEcCtD
Fluocinolone Acetonide—NR3C1—nerve—skin cancer	0.000486	0.102	CbGeAlD
Fluocinolone Acetonide—Upper respiratory tract infection—Imiquimod—skin cancer	0.000486	0.0036	CcSEcCtD
Fluocinolone Acetonide—Pain—Vismodegib—skin cancer	0.000483	0.00358	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Vemurafenib—skin cancer	0.000482	0.00358	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Imiquimod—skin cancer	0.000466	0.00346	CcSEcCtD
Fluocinolone Acetonide—Infestation—Imiquimod—skin cancer	0.000466	0.00346	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Temozolomide—skin cancer	0.000461	0.00342	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Vemurafenib—skin cancer	0.000459	0.0034	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Fluorouracil—skin cancer	0.000455	0.00337	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—connective tissue—skin cancer	0.000449	0.0942	CbGeAlD
Fluocinolone Acetonide—Mediastinal disorder—Vemurafenib—skin cancer	0.000442	0.00328	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Imiquimod—skin cancer	0.000438	0.00324	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Vemurafenib—skin cancer	0.000434	0.00322	CcSEcCtD
Fluocinolone Acetonide—Photophobia—Fluorouracil—skin cancer	0.000432	0.0032	CcSEcCtD
Fluocinolone Acetonide—Erythema—Vemurafenib—skin cancer	0.000427	0.00317	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Vemurafenib—skin cancer	0.000427	0.00317	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Docetaxel—skin cancer	0.000427	0.00316	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Temozolomide—skin cancer	0.000425	0.00315	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Imiquimod—skin cancer	0.00042	0.00311	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Vemurafenib—skin cancer	0.000419	0.0031	CcSEcCtD
Fluocinolone Acetonide—Back pain—Vemurafenib—skin cancer	0.000413	0.00306	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Imiquimod—skin cancer	0.000411	0.00305	CcSEcCtD
Fluocinolone Acetonide—Rhinorrhoea—Docetaxel—skin cancer	0.00041	0.00304	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Temozolomide—skin cancer	0.000409	0.00303	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Imiquimod—skin cancer	0.000403	0.00299	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Temozolomide—skin cancer	0.000402	0.00298	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Vismodegib—skin cancer	0.000399	0.00296	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Imiquimod—skin cancer	0.000391	0.0029	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Docetaxel—skin cancer	0.000389	0.00288	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vismodegib—skin cancer	0.000386	0.00286	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Imiquimod—skin cancer	0.000377	0.0028	CcSEcCtD
Fluocinolone Acetonide—Cough—Vemurafenib—skin cancer	0.000373	0.00276	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Imiquimod—skin cancer	0.00037	0.00274	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—mammalian vulva—skin cancer	0.00037	0.0776	CbGeAlD
Fluocinolone Acetonide—Mental disorder—Imiquimod—skin cancer	0.000367	0.00272	CcSEcCtD
Fluocinolone Acetonide—Erythema—Imiquimod—skin cancer	0.000364	0.0027	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Imiquimod—skin cancer	0.000364	0.0027	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Vemurafenib—skin cancer	0.000364	0.0027	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Temozolomide—skin cancer	0.000363	0.00269	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Docetaxel—skin cancer	0.000361	0.00267	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vismodegib—skin cancer	0.000359	0.00266	CcSEcCtD
Fluocinolone Acetonide—Rash—Vismodegib—skin cancer	0.000356	0.00264	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vismodegib—skin cancer	0.000356	0.00264	CcSEcCtD
Fluocinolone Acetonide—Back pain—Imiquimod—skin cancer	0.000353	0.00261	CcSEcCtD
Fluocinolone Acetonide—Infection—Vemurafenib—skin cancer	0.000347	0.00257	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Vemurafenib—skin cancer	0.000342	0.00254	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vismodegib—skin cancer	0.000335	0.00249	CcSEcCtD
Fluocinolone Acetonide—Cough—Imiquimod—skin cancer	0.000318	0.00236	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000318	0.00236	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—female reproductive system—skin cancer	0.000317	0.0665	CbGeAlD
Fluocinolone Acetonide—SERPINA6—female reproductive system—skin cancer	0.000315	0.0662	CbGeAlD
Fluocinolone Acetonide—Arthralgia—Imiquimod—skin cancer	0.00031	0.0023	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000301	0.00223	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Fluorouracil—skin cancer	0.000299	0.00221	CcSEcCtD
Fluocinolone Acetonide—Oedema—Imiquimod—skin cancer	0.000297	0.0022	CcSEcCtD
Fluocinolone Acetonide—Infection—Imiquimod—skin cancer	0.000296	0.00219	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Imiquimod—skin cancer	0.000292	0.00216	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Temozolomide—skin cancer	0.000291	0.00216	CcSEcCtD
Fluocinolone Acetonide—Infestation—Temozolomide—skin cancer	0.000279	0.00207	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Temozolomide—skin cancer	0.000279	0.00207	CcSEcCtD
Fluocinolone Acetonide—NR3C1—nipple—skin cancer	0.000276	0.058	CbGeAlD
Fluocinolone Acetonide—Body temperature increased—Vemurafenib—skin cancer	0.000276	0.00204	CcSEcCtD
Fluocinolone Acetonide—NR3C1—neck—skin cancer	0.000273	0.0573	CbGeAlD
Fluocinolone Acetonide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000271	0.00201	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000268	0.00199	CcSEcCtD
Fluocinolone Acetonide—SERPINA6—head—skin cancer	0.000263	0.0553	CbGeAlD
Fluocinolone Acetonide—Alopecia—Bleomycin—skin cancer	0.000263	0.00195	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Temozolomide—skin cancer	0.000262	0.00194	CcSEcCtD
Fluocinolone Acetonide—Erythema—Bleomycin—skin cancer	0.000259	0.00192	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Fluorouracil—skin cancer	0.000258	0.00191	CcSEcCtD
Fluocinolone Acetonide—Infestation—Fluorouracil—skin cancer	0.000258	0.00191	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vemurafenib—skin cancer	0.000257	0.0019	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Imiquimod—skin cancer	0.000257	0.0019	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Docetaxel—skin cancer	0.000255	0.00189	CcSEcCtD
Fluocinolone Acetonide—Pain—Imiquimod—skin cancer	0.000254	0.00189	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Vemurafenib—skin cancer	0.000247	0.00183	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Temozolomide—skin cancer	0.000247	0.00183	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Dactinomycin—skin cancer	0.000245	0.00182	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Temozolomide—skin cancer	0.000242	0.00179	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Fluorouracil—skin cancer	0.000242	0.00179	CcSEcCtD
Fluocinolone Acetonide—Erythema—Dactinomycin—skin cancer	0.000241	0.00179	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Docetaxel—skin cancer	0.000241	0.00179	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vemurafenib—skin cancer	0.000239	0.00177	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Imiquimod—skin cancer	0.000235	0.00174	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Temozolomide—skin cancer	0.000234	0.00174	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Fluorouracil—skin cancer	0.000232	0.00172	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vemurafenib—skin cancer	0.000231	0.00171	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Temozolomide—skin cancer	0.000226	0.00168	CcSEcCtD
Fluocinolone Acetonide—Cough—Bleomycin—skin cancer	0.000226	0.00167	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vemurafenib—skin cancer	0.000222	0.00164	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Temozolomide—skin cancer	0.000222	0.00164	CcSEcCtD
Fluocinolone Acetonide—Rash—Vemurafenib—skin cancer	0.00022	0.00163	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Temozolomide—skin cancer	0.00022	0.00163	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vemurafenib—skin cancer	0.00022	0.00163	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Imiquimod—skin cancer	0.000219	0.00162	CcSEcCtD
Fluocinolone Acetonide—Headache—Vemurafenib—skin cancer	0.000219	0.00162	CcSEcCtD
Fluocinolone Acetonide—Erythema—Temozolomide—skin cancer	0.000218	0.00162	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Temozolomide—skin cancer	0.000218	0.00162	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Docetaxel—skin cancer	0.000216	0.0016	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Temozolomide—skin cancer	0.000214	0.00159	CcSEcCtD
Fluocinolone Acetonide—Oedema—Bleomycin—skin cancer	0.000211	0.00157	CcSEcCtD
Fluocinolone Acetonide—Back pain—Temozolomide—skin cancer	0.000211	0.00157	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Imiquimod—skin cancer	0.00021	0.00156	CcSEcCtD
Fluocinolone Acetonide—Infection—Bleomycin—skin cancer	0.00021	0.00156	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vemurafenib—skin cancer	0.000207	0.00154	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Temozolomide—skin cancer	0.000206	0.00153	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Fluorouracil—skin cancer	0.000204	0.00151	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Imiquimod—skin cancer	0.000204	0.00151	CcSEcCtD
Fluocinolone Acetonide—Erythema—Fluorouracil—skin cancer	0.000201	0.00149	CcSEcCtD
Fluocinolone Acetonide—Oedema—Dactinomycin—skin cancer	0.000197	0.00146	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Imiquimod—skin cancer	0.000197	0.00146	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Temozolomide—skin cancer	0.000196	0.00145	CcSEcCtD
Fluocinolone Acetonide—NR3C1—connective tissue—skin cancer	0.000196	0.0411	CbGeAlD
Fluocinolone Acetonide—Infection—Dactinomycin—skin cancer	0.000196	0.00145	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000193	0.00143	CcSEcCtD
Fluocinolone Acetonide—Cough—Temozolomide—skin cancer	0.000191	0.00141	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Fluorouracil—skin cancer	0.00019	0.00141	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Imiquimod—skin cancer	0.000189	0.0014	CcSEcCtD
Fluocinolone Acetonide—Rash—Imiquimod—skin cancer	0.000188	0.00139	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Imiquimod—skin cancer	0.000187	0.00139	CcSEcCtD
Fluocinolone Acetonide—Headache—Imiquimod—skin cancer	0.000186	0.00138	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Temozolomide—skin cancer	0.000186	0.00138	CcSEcCtD
Fluocinolone Acetonide—NR3C1—epithelium—skin cancer	0.000186	0.039	CbGeAlD
Fluocinolone Acetonide—Infestation—Docetaxel—skin cancer	0.000186	0.00138	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Docetaxel—skin cancer	0.000186	0.00138	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—lymph node—skin cancer	0.000185	0.0389	CbGeAlD
Fluocinolone Acetonide—Triamcinolone—PTGS2—skin cancer	0.000184	0.0711	CrCbGaD
Fluocinolone Acetonide—Pain—Bleomycin—skin cancer	0.000181	0.00134	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00018	0.00133	CcSEcCtD
Fluocinolone Acetonide—Oedema—Temozolomide—skin cancer	0.000178	0.00132	CcSEcCtD
Fluocinolone Acetonide—Infection—Temozolomide—skin cancer	0.000177	0.00131	CcSEcCtD
Fluocinolone Acetonide—NR3C1—skin of body—skin cancer	0.000177	0.0371	CbGeAlD
Fluocinolone Acetonide—Nausea—Imiquimod—skin cancer	0.000177	0.00131	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Temozolomide—skin cancer	0.000175	0.0013	CcSEcCtD
Fluocinolone Acetonide—Pain—Dactinomycin—skin cancer	0.000169	0.00125	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Docetaxel—skin cancer	0.000167	0.00124	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Bleomycin—skin cancer	0.000167	0.00124	CcSEcCtD
Fluocinolone Acetonide—Oedema—Fluorouracil—skin cancer	0.000164	0.00122	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Docetaxel—skin cancer	0.000164	0.00122	CcSEcCtD
Fluocinolone Acetonide—Infection—Fluorouracil—skin cancer	0.000163	0.00121	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000162	0.0012	CcSEcCtD
Fluocinolone Acetonide—NR3C1—mammalian vulva—skin cancer	0.000161	0.0338	CbGeAlD
Fluocinolone Acetonide—Nervous system disorder—Fluorouracil—skin cancer	0.000161	0.00119	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Docetaxel—skin cancer	0.000161	0.00119	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Docetaxel—skin cancer	0.000156	0.00116	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dactinomycin—skin cancer	0.000156	0.00115	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Bleomycin—skin cancer	0.000156	0.00115	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Temozolomide—skin cancer	0.000154	0.00114	CcSEcCtD
Fluocinolone Acetonide—Pain—Temozolomide—skin cancer	0.000152	0.00113	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—skin cancer	0.000151	0.0582	CrCbGaD
Fluocinolone Acetonide—Mediastinal disorder—Docetaxel—skin cancer	0.00015	0.00111	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00015	0.00111	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Bleomycin—skin cancer	0.00015	0.00111	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Docetaxel—skin cancer	0.000147	0.00109	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Docetaxel—skin cancer	0.000146	0.00108	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Docetaxel—skin cancer	0.000145	0.00108	CcSEcCtD
Fluocinolone Acetonide—Erythema—Docetaxel—skin cancer	0.000145	0.00108	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Dactinomycin—skin cancer	0.000145	0.00108	CcSEcCtD
Fluocinolone Acetonide—NR3C1—lymphoid tissue—skin cancer	0.000143	0.0301	CbGeAlD
Fluocinolone Acetonide—Dysgeusia—Docetaxel—skin cancer	0.000142	0.00105	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000142	0.00105	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Temozolomide—skin cancer	0.000141	0.00104	CcSEcCtD
Fluocinolone Acetonide—Back pain—Docetaxel—skin cancer	0.00014	0.00104	CcSEcCtD
Fluocinolone Acetonide—Pain—Fluorouracil—skin cancer	0.00014	0.00104	CcSEcCtD
Fluocinolone Acetonide—NR3C1—female reproductive system—skin cancer	0.000138	0.029	CbGeAlD
Fluocinolone Acetonide—Diarrhoea—Dactinomycin—skin cancer	0.000135	0.000999	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Bleomycin—skin cancer	0.000134	0.000996	CcSEcCtD
Fluocinolone Acetonide—Rash—Bleomycin—skin cancer	0.000133	0.000988	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Bleomycin—skin cancer	0.000133	0.000987	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Temozolomide—skin cancer	0.000131	0.000973	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Fluorouracil—skin cancer	0.00013	0.000962	CcSEcCtD
Fluocinolone Acetonide—Cough—Docetaxel—skin cancer	0.000127	0.000939	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Temozolomide—skin cancer	0.000126	0.000935	CcSEcCtD
Fluocinolone Acetonide—Nausea—Bleomycin—skin cancer	0.000126	0.00093	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Dactinomycin—skin cancer	0.000125	0.000929	CcSEcCtD
Fluocinolone Acetonide—Rash—Dactinomycin—skin cancer	0.000124	0.000921	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Docetaxel—skin cancer	0.000124	0.000917	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Temozolomide—skin cancer	0.000122	0.000904	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Fluorouracil—skin cancer	0.000121	0.000897	CcSEcCtD
Fluocinolone Acetonide—Oedema—Docetaxel—skin cancer	0.000119	0.000879	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Temozolomide—skin cancer	0.000118	0.000874	CcSEcCtD
Fluocinolone Acetonide—Infection—Docetaxel—skin cancer	0.000118	0.000873	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dactinomycin—skin cancer	0.000117	0.000868	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Docetaxel—skin cancer	0.000116	0.000862	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Fluorouracil—skin cancer	0.000116	0.000861	CcSEcCtD
Fluocinolone Acetonide—NR3C1—head—skin cancer	0.000115	0.0242	CbGeAlD
Fluocinolone Acetonide—Vomiting—Temozolomide—skin cancer	0.000113	0.00084	CcSEcCtD
Fluocinolone Acetonide—Rash—Temozolomide—skin cancer	0.000112	0.000833	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Fluorouracil—skin cancer	0.000112	0.000833	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Temozolomide—skin cancer	0.000112	0.000832	CcSEcCtD
Fluocinolone Acetonide—Headache—Temozolomide—skin cancer	0.000112	0.000828	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Fluorouracil—skin cancer	0.000109	0.000805	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000108	0.0008	CcSEcCtD
Fluocinolone Acetonide—Nausea—Temozolomide—skin cancer	0.000106	0.000785	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Fluorouracil—skin cancer	0.000104	0.000774	CcSEcCtD
Fluocinolone Acetonide—Rash—Fluorouracil—skin cancer	0.000104	0.000768	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Fluorouracil—skin cancer	0.000103	0.000767	CcSEcCtD
Fluocinolone Acetonide—Headache—Fluorouracil—skin cancer	0.000103	0.000763	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000102	0.000759	CcSEcCtD
Fluocinolone Acetonide—Pain—Docetaxel—skin cancer	0.000101	0.000751	CcSEcCtD
Fluocinolone Acetonide—Nausea—Fluorouracil—skin cancer	9.76e-05	0.000723	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Docetaxel—skin cancer	9.37e-05	0.000695	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—PTGS2—skin cancer	8.76e-05	0.0339	CrCbGaD
Fluocinolone Acetonide—Hypersensitivity—Docetaxel—skin cancer	8.73e-05	0.000647	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Docetaxel—skin cancer	8.39e-05	0.000622	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Docetaxel—skin cancer	8.11e-05	0.000601	CcSEcCtD
Fluocinolone Acetonide—NR3C1—lymph node—skin cancer	8.08e-05	0.017	CbGeAlD
Fluocinolone Acetonide—Dizziness—Docetaxel—skin cancer	7.84e-05	0.000581	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Docetaxel—skin cancer	7.54e-05	0.000559	CcSEcCtD
Fluocinolone Acetonide—Rash—Docetaxel—skin cancer	7.47e-05	0.000554	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Docetaxel—skin cancer	7.47e-05	0.000553	CcSEcCtD
Fluocinolone Acetonide—Headache—Docetaxel—skin cancer	7.43e-05	0.00055	CcSEcCtD
Fluocinolone Acetonide—Nausea—Docetaxel—skin cancer	7.04e-05	0.000522	CcSEcCtD
